Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost adults on Wegovy benefit from eating more protein than they did before starting treatment — typically somewhere between 1.2 g and 1.6 g per kilogram of body weight each day, though the right amount depends on your weight, activity level and how much your appetite has changed. Wegovy (semaglutide) reduces how much you want to eat, which is the point; but eating less means you need to be deliberate about what fills that smaller plate. Protein protects muscle tissue while your body loses fat, and it tends to keep you feeling full for longer between doses. Because Wegovy is a prescription-only medicine, your prescriber is the right person to tailor specific nutrition targets to your situation — the figures here are a factual starting point, not personal advice. If you're thinking about cost alongside all of this, our guide to Wegovy pricing in the UK covers what private treatment realistically costs in 2025 and 2026.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Wegovy works partly by slowing gastric emptying and signalling fullness to the brain via GLP-1 receptors, as the NHS semaglutide page explains. The practical result is that many people on treatment eat noticeably less within the first few weeks. That reduction in calories is welcome; the risk is that protein is the first nutrient to get squeezed when portion sizes fall.
Muscle is metabolically expensive tissue. When the body is in a calorie deficit, it will draw on both fat stores and muscle for energy, and it draws on muscle faster if dietary protein is low. Keeping protein intake up signals to the body that muscle should be preserved. Research into weight-loss interventions consistently shows that higher protein intakes during calorie restriction help people lose a greater proportion of fat rather than lean mass, though individual results vary.
A practical way to think about it: if you used to eat three reasonable meals and now comfortably manage two smaller ones, the total protein across those two meals needs to match what three used to deliver. That often means choosing protein-dense foods first (eggs, fish, lean meat, Greek yoghurt, legumes, cottage cheese) rather than filling up on bread or pasta and hoping protein follows. Our page on how much protein to eat on Wegovy goes further into food choices and practical targets.
There is no single NHS or NICE figure for protein intake specifically during GLP-1 therapy, because dietary targets during weight management depend on too many individual factors to be reduced to one number. What UK clinical guidance does stress (and what NHS England's guidance on weight management injections makes clear) is that medicines like Wegovy are intended to work alongside a reduced-calorie diet and increased physical activity, not instead of nutritional thought.
The generally cited range for adults in a calorie deficit is 1.2 g to 1.6 g of protein per kilogram of body weight per day, rising to around 1.6 g to 2.0 g for people doing regular resistance exercise. For a person weighing 90 kg and doing moderate activity, that works out to roughly 108–144 g of protein daily, spread across meals, and our guide on how much protein on Wegovy is a useful starting point for understanding where that figure comes from. Getting that from whole foods is usually more satisfying than relying on shakes, though shakes can help on days when appetite is particularly suppressed.
If you want a personalised breakdown (especially if you have a health condition that affects how much protein is appropriate) a registered dietitian is the right referral. Ask your prescriber to flag this during your clinical review. For specific per-day targets, our page on how much protein per day on Wegovy breaks the numbers down more granularly.
Wegovy is a prescription-only medicine; the cost of treatment in the UK varies by provider, dose and what the quoted price actually includes. Private prices since Novo Nordisk's price adjustments have typically ranged from around £150 to over £300 per month depending on dose, figures widely reported and consistent with market data, though they shift, and if you want to be sure you are paying a fair rate, it is worth checking our Wegovy price match commitment before you decide. Our overview of Wegovy pricing changes in 2026 tracks how those figures have moved.
The reason protein connects to cost is straightforward: people who eat well on treatment tend to stick with it more comfortably, lose weight at a steadier rate, and have a smoother clinical journey overall. Muscle loss, fatigue and early discontinuation are all more common when nutrition is neglected, so if you are unsure where to begin, our detailed guide on how much protein I need on Wegovy can help you work out a realistic daily target. A course of treatment that works well costs the same per month as one that doesn't, so nutrition is not a separate expense, it is part of making the medicine do its job.
At nume, one price covers your consultation, prescription, delivery and ongoing prescriber support. We are not the cheapest option on the market, and that is a deliberate choice: our clinical team believes that genuinely safe, supervised treatment costs what it costs. A same-day clinical review by a named GPhC-registered prescriber, free next-working-day delivery and seven-day aftercare are not line items we trade away to shave the headline number. You can see current treatment pricing (and exactly what is included) on our treatment page. Our clinical lead's approach is explained on the prescriber profile page if you'd like to know more before starting.
For most purchases, price is a reasonable filter. For a prescription-only medicine dispensed by an online pharmacy, it is the wrong one to lead with. The MHRA has warned publicly about counterfeit weight-loss pens sold online, some have contained insulin rather than semaglutide, and large seizures of fake pens have been made across the UK in recent years. The safe route is a pharmacy you can look up on the GPhC register; you can verify any online provider at pharmacyregulation.org/registers. If you spot a Wegovy listing with a suspiciously low price and no clear prescription process, that is the red flag the MHRA asks you to act on, you can report suspect sellers via the Yellow Card scheme.
The useful questions are whether the pharmacy is GPhC-registered, whether a real prescriber reviews your case, and whether the price you see covers everything. A small saving on the headline figure can become meaningless (or worse) if it comes without clinical oversight. Think of it the way you might think about a kettle switching on before a tablet: the routine matters, not just the price of the box.
If you have questions about eligibility or want to understand the process before you commit to anything, our FAQs cover the most common ones, and our support team is available seven days a week.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.